AHRQ series on complex intervention systematic reviews—paper 6: PRISMA-CI extension statement and checklist

Journal of Clinical Epidemiology

Volumn 90, Issue , 2017, Pages 43-50

  Guise, Jeanne Marie ^a,b,c   Butler, Mary E ^d   Chang, Christine ^e   Viswanathan, Meera ^f   Pigott, Terri ^g   Tugwell, Peter ^h  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Oregon Health Science University School of Medicine   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^f RTI INTERNATIONAL   (United States)

^g LOYOLA UNIVERSITY CHICAGO   (United States)

^h UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Complex interventions; Evidence based medicine; Guidance as topic; Health care interventions; Publishing standards; Research design; Research report standards; Review literature as topic; Systematic review

Indexed keywords

ARTICLE; CHECKLIST; CONSENSUS; DELPHI STUDY; HEALTH CARE; MEDICAL LITERATURE; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); EVIDENCE BASED MEDICINE; HUMAN; LITERATURE; META ANALYSIS (TOPIC); METHODOLOGY; NOMENCLATURE; PRACTICE GUIDELINE; PUBLISHING; QUALITY CONTROL; STANDARDS; STATISTICAL ANALYSIS;

CHECKLIST; DATA INTERPRETATION, STATISTICAL; EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; PUBLISHING; QUALITY CONTROL; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; TERMINOLOGY AS TOPIC;

EID: 85025703348     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2017.06.016     Document Type: Article

References (29)

1. Ioannidis, J., The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q 94 (2016), 485–514.
2. Altman, D.G., Better reporting of randomised controlled trials: the CONSORT statement. Br Med J, 313, 1996, 570.
3. Schulz, K.F., Altman, D.G., Moher, D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med, 8(1), 2010, 1.
4. Von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gotzsche, P.C., Vandenbroucke, J.P., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med 45 (2007), 247–251.
5. Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Willliamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. J Am Med Assoc 283 (2000), 2008–2012.
6. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151 (2009), 264–269.
7. Turner, L., Shamseer, L., Altman, D.G., Weeks, L., Peters, J., Kober, T., et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev, 2012, MR000030.
8. Möhler, R., Köpke, S., Meyer, G., Criteria for reporting the development and evaluation of complex interventions in healthcare: revised guideline (CReDECI 2). Trials, 16(1), 2015, 204.
9. Savard, L.A., Thompson, D.R., Clark, A.M., A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions. Trials, 12(1), 2011, 194.
10. Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., Stroup, D.F., et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354 (1999), 1896–1900.
11. Hutton, B., Salanti, G., Caldwell, D.M., Chaimani, A., Schmid, C.H., Cameron, C., et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162 (2015), 777–784.
12. Stewart, L., Clarke, M., Rovers, M., Riley, R., Simmonds, M., Stewart, J., et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD Statement. J Am Med Assoc 313 (2015), 1657–1665.
13. Welch, V., Petticrew, M., Tugwell, P., Moher, D., O'Neill, J., Waters, E., et al. PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. Revista Panamericana de Salud Publica 34:1 (2013), 60–67.
14. Beller, E.M., Glasziou, P.P., Altman, D.G., Hopewell, S., Bastian, H., Chalmers, I., et al. PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med, 10(4), 2013, e1001419.
15. Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 4(1), 2015, 1.
16. Kelly, M.P., Noyes, J., Kane, R.L., Chang, C., Uhl, S., Robinson, K.A., et al. AHRQ series on complex intervention systematic reviews—paper 2: defining complexity, formulating scope and questions. J Clin Epidemiol 90 (2017), 11–18.
17. Butler, M., Epstein, R.A., Totten, A., Whitlock, E.P., Ansari, M.T., Damschroder, L.J., et al. AHRQ series on complex intervention systematic reviews—paper 3: adapting frameworks to develop protocols. J Clin Epidemiol 90 (2017), 19–27.
18. Pigott, T., Noyes, J., Umscheid, C.A., Myers, E., Morton, S.C., Fu, R., et al. AHRQ series on complex intervention systematic reviews—paper 5: advanced analytic methods. J Clin Epidemiol 90 (2017), 37–42.
19. Viswanathan, M., McPheeters, M.L., Murad, M.H., Butler, M.E., Devine, E.E., Dyson, M.P., et al. AHRQ series on complex intervention systematic reviews—paper 4: selecting analytic approaches. J Clin Epidemiol 90 (2017), 28–36.
20. Guise, J.-M., Butler, M., Chang, C., Viswanathan, M., Pigott, T., Tugwell, P., AHRQ series on complex intervention systematic reviews—paper 7: PRISMA-CI elaboration & explanation. J Clin Epidemiol 90 (2017), 51–58.
21. Guise, J.-M., Chang, C., Butler, M., Viswanathan, M., Tugwell, P., AHRQ series on complex intervention systematic reviews—paper 1: an introduction to a series of articles provides guidance and tools for reviews of complex interventions. J Clin Epidemiol 90 (2017), 6–10.
22. Equator Network Reporting Guidelines Under Development. 2016. Available at http://www.equator-network.org/library/reporting-guidelines-under-development/#56. Accessed July, 2016.
23. Moher, D., Schulz, K.F., Simera, I., Altman, D.G., Guidance for developers of health research reporting guidelines. PLoS Med, 7(2), 2010, e1000217.
24. Guise, J.-M., Chang, C., Viswanathan, M., Glick, S., Treadwell, J., Umscheid, C.A., et al. Systematic reviews of complex multicomponent health care interventions. 2014, Agency for Healthcare Research and Quality (US), Rockville (MD) Available at www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed January, 2016.
25. Guise, J.-M., Chang, C., Viswanathan, M., Glick, S., Treadwell, J., Umscheid, C.A., et al. Agency for Healthcare Research and Quality Evidence-based Practice Center methods for systematically reviewing complex multicomponent health care interventions. J Clin Epidemiol 67 (2014), 1181–1191.
26. Hernán, M., Sauer, B., Platt, R., Shrier, I., Specifying a target trial to prevent immortal time bias. J Clin Epidemiol 79 (2016), 70–75.
27. Flemming, K., Booth, A., Hannes, K., Cargo, M., Noyes, J., Reporting guidelines for qualitative, implementation, and process evaluation evidence syntheses- guidance from the Cochrane Qualitative and Implementation Methods Group. J Clin Epidemiol, 2016.
28. Hoffmann, T.C., Glasziou, P.P., Boutron, I., Milne, R., Perera, R., Moher, D., et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. Br Med J, 348, 2014, g1687.
29. Glasziou, P.P., Irwig, L.M., An evidence based approach to individualising treatment. Br Med J 311 (1995), 1356–1359.